CUA Educational Content

The Radioligand Therapy (RLT) Revolution in Prostate Cancer: Is Canada Ready?


Featuring: Kim Chi, Frédéric Pouliot, Stephan Probst

 
Description: 

  • What is RLT, and what RLT therapies are under investigation in this space?
  • Requirements to implement RLT across Canada.
  • Existing gaps in infrastructure for RLT implementation and how these can be bridged to ensure access to patients from coast to coast.
Start Quiz for Credits

ACCREDITATION

This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the Canadian Urological Association. You may claim a maximum of 1 hour of credit.

This program has received financial support from Advanced Accelerator Applications: A Novartis Company in the form of an educational grant.

The Canadian Urological Association (CUA) does not provide professional medical advice, diagnosis or treatment and cannot respond to requests for direct feedback, specific patient information or physician referrals. You should first always seek the advice of your urologist, physician and other qualified health provider with any questions regarding your medical condition. The contents of the CUA Website such as text, graphics, images, and other content are for informational purposes only. The content/information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on the CUA website.

For comments or information, email Corporate.office@cua.org

Privacy Policy